Product
OCU400
1 clinical trial
2 indications
Indication
Retinitis PigmentosaIndication
Leber congenital amaurosisClinical trial
A Phase 1/2 Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa Associated With NR2E3 and RHO Mutations and Leber Congenital Amaurosis With Mutation(s) in CEP290 GeneStatus: Recruiting, Estimated PCD: 2024-12-01